AAV based gamma delta T cell therapy(Expression Therapeutics)

N/A

Report date: 2023/10/26 16:51:07

Base Information

Drug NameAAV based gamma delta T cell therapy(Expression Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsLymphoma, T-CellLeukemia, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExpression Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesExpression Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsLymphoma, T-CellLeukemia, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A